BioLineRx BLRX
NASDAQ BLRX
$2.36 -0.07 (-2.88%)
As of: Sep 29, 2026 · 3:07 PM EDT

BioLineRx (BLRX) Asset Utilization Ratio (2024 - 2026)

Updated

BioLineRx's Asset Utilization Ratio came in at 0.03 for the quarter ended Jun 30, 2026, down 91.5% from 0.40 a year earlier.

Analysis

BioLineRx (BLRX) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Going back to the quarter ended Sep 30, 2024, BioLineRx's Asset Utilization Ratio data covers 7 quarters.

  • Going back by year, Asset Utilization Ratio was 0.56 in the year ended Dec 31, 2024 (+722.7%) and 0.07 in the year ended Dec 31, 2023.
  • The five-year range for quarterly Asset Utilization Ratio is 0.03 (the quarter ended Dec 31, 2025) to 0.63 (the quarter ended Dec 31, 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.49
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.47
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.52
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.44
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.53
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.40
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.58
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 0.47
10 BioLineRx 6.34 Bn 6.35 Bn 235,000.00 0.03
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.03
Dec 31, 2025 0.03
Sep 30, 2025 0.31
Jun 30, 2025 0.40
Mar 31, 2025 0.54
Dec 31, 2024 0.63
Sep 30, 2024 0.29
API Access

BioLineRx Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=BLRX&period=max&api_key=YOUR_API_KEY